244 related articles for article (PubMed ID: 12369443)
1. [Increased perioperative blood loss during treatment with paroxetine].
Sewnath ME; van Hillegersberg R; Koopman MM; Levi MM; Gouma DJ
Ned Tijdschr Geneeskd; 2002 Sep; 146(38):1800-2. PubMed ID: 12369443
[TBL] [Abstract][Full Text] [Related]
2. [Increased perioperative blood loss during treatment with paroxetine].
Movig KL; Meijer WE; Heerdink ER; Leufkens HG; Egberts AC
Ned Tijdschr Geneeskd; 2002 Dec; 146(52):2564-5; author reply 2565. PubMed ID: 12532672
[No Abstract] [Full Text] [Related]
3. [Paroxetine (paxil): use in clinical practice].
Litvintsev SV; Reznik AM; Arbuzov AL; Mironychev GN
Voen Med Zh; 2002 Jan; 323(1):35-9. PubMed ID: 11881199
[No Abstract] [Full Text] [Related]
4. Ask the doctor. I have been taking an SSRI (paroxetine HCI) for many years for chronic anxiety and, at times, panic attacks. What are the side effects of the long-term use of SSRIs?
Komaroff AL
Harv Health Lett; 2012 Aug; 37(10):2. PubMed ID: 22991725
[No Abstract] [Full Text] [Related]
5. Paroxetine use in medically ill patients.
Stout SS; Somerset WI; Miller A; Musselman DL
Psychopharmacol Bull; 2003; 37 Suppl 1():108-22. PubMed ID: 14566206
[TBL] [Abstract][Full Text] [Related]
6. Serotonin syndrome in a prisoner.
Zimmerschied JA; Harry B
J Forensic Sci; 1998 Jan; 43(1):208-9. PubMed ID: 9456547
[TBL] [Abstract][Full Text] [Related]
7. Focus on paroxetine.
Green B
Curr Med Res Opin; 2003; 19(1):13-21. PubMed ID: 12661775
[TBL] [Abstract][Full Text] [Related]
8. Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.
Satoh K; Takano S; Onogi T; Ohtsuki K; Kobayashi T
Fukushima J Med Sci; 2006 Jun; 52(1):29-33. PubMed ID: 16995352
[TBL] [Abstract][Full Text] [Related]
9. Withdrawal syndromes after paroxetine and sertraline discontinuation.
Fava GA; Grandi S
J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
[No Abstract] [Full Text] [Related]
10. Paroxetine treatment of trichotillomania in an adolescent.
Block C; West SA; Baharoglu B
J Child Adolesc Psychopharmacol; 1998; 8(1):69-71. PubMed ID: 9639081
[TBL] [Abstract][Full Text] [Related]
11. Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease.
Roose SP; Laghrissi-Thode F; Kennedy JS; Nelson JC; Bigger JT; Pollock BG; Gaffney A; Narayan M; Finkel MS; McCafferty J; Gergel I
JAMA; 1998 Jan; 279(4):287-91. PubMed ID: 9450712
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous ecchymoses due to paroxetine administration.
Cooper TA; Valcour VG; Gibbons RB; O'Brien-Falls K
Am J Med; 1998 Feb; 104(2):197-8. PubMed ID: 9528740
[No Abstract] [Full Text] [Related]
13. Paroxetine in the treatment of generalised anxiety disorder.
Snyderman SH; Rynn MA; Bellew K; Rickels K
Expert Opin Pharmacother; 2004 Aug; 5(8):1799-806. PubMed ID: 15264994
[TBL] [Abstract][Full Text] [Related]
14. Paroxetine for the treatment of depression: a critical update.
Gibiino S; Serretti A
Expert Opin Pharmacother; 2012 Feb; 13(3):421-31. PubMed ID: 22263916
[TBL] [Abstract][Full Text] [Related]
15. [Chronic cough under treatment with paroxetine].
Hamel H; Bonniaud P; Sgro C; Foucher P; Camus P
Presse Med; 2000 May 27-Jun 3; 29(19):1045. PubMed ID: 10874912
[No Abstract] [Full Text] [Related]
16. [Comparative efficacy and tolerability of paroxetine and amitriptiline in long-term therapy preventing depressive recurrences].
Mosolov SN; Kostiukova EG; Gorodnichev AV; Timofeev IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(10):22-9. PubMed ID: 16281375
[TBL] [Abstract][Full Text] [Related]
17. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
Gunasekara NS; Noble S; Benfield P
Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
[TBL] [Abstract][Full Text] [Related]
18. Differential effects of milnacipran, fluvoxamine and paroxetine for depression, especially in gender.
Morishita S; Arita S
Eur Psychiatry; 2003 Dec; 18(8):418-20. PubMed ID: 14680720
[No Abstract] [Full Text] [Related]
19. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
20. Effect of nortriptyline and paroxetine on extrapyramidal signs and symptoms: A prospective double-blind study in depressed elderly patients.
Mamo DC; Sweet RA; Mulsant BH; Pollock BG; Miller MD; Stack JA; Begley AE; Reynolds CF
Am J Geriatr Psychiatry; 2000; 8(3):226-31. PubMed ID: 10910421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
